Aclaris Therapeutics
ACRS
ACRS
80 hedge funds and large institutions have $58.5M invested in Aclaris Therapeutics in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 29 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
18% less funds holding
Funds holding: 97 → 80 (-17)
28% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 29
68% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 25
Holders
80
Holding in Top 10
1
Calls
$67K
Puts
$6K
Top Buyers
| 1 | +$1.45M | |
| 2 | +$1.05M | |
| 3 | +$611K | |
| 4 |
Renaissance Technologies
New York
|
+$516K |
| 5 |
Morgan Stanley
New York
|
+$339K |
Top Sellers
| 1 | -$1.1M | |
| 2 | -$745K | |
| 3 | -$707K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$587K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$452K |